Tonix Pharmaceuticals Holding Corp. (TNXP) Insider Trading Activity

NASDAQ$5.125-0.07 (-1.35%)
Market Cap
$89.01M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
179 of 849
Rank in Industry
105 of 491

TNXP Insider Trading Activity

TNXP Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$458,758
7
100
Sells
$0
0
0

Related Transactions

LEDERMAN SETHChief Executive Officer
4
$372,980
0
$0
$372,980
Stillwell Richard Newcombdirector
1
$58,250
0
$0
$58,250
Taylor Carolyn E.director
1
$14,928
0
$0
$14,928
BAGGER RICHARD Hdirector
1
$12,600
0
$0
$12,600

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage. Its overarching mission involves the discovery, acquisition, advancement, and commercialization of novel therapeutic agents and diagnostic tools, all aimed at combating human illnesses and easing patient discomfort. The company boasts a comprehensive pipeline of potential treatments spanning several key medical fields: immunology, rare conditions, infectious diseases, and central nervous system (CNS) disorders. In the realm of …

Insider Activity of Tonix Pharmaceuticals Holding Corp.

Over the last 12 months, insiders at Tonix Pharmaceuticals Holding Corp. have bought $458,758 and sold $0 worth of Tonix Pharmaceuticals Holding Corp. stock.

On average, over the past 5 years, insiders at Tonix Pharmaceuticals Holding Corp. have bought $209,240 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: LEDERMAN SETH (Chief Executive Officer) — $372,980. Stillwell Richard Newcomb (director) — $58,250. Taylor Carolyn E. (director) — $14,928.

The last purchase of 2,000 shares for transaction amount of $27,580 was made by LEDERMAN SETH (Chief Executive Officer) on 2026‑08‑27.

List of Insider Buy and Sell Transactions, Tonix Pharmaceuticals Holding Corp.

2026-08-27PurchaseLEDERMAN SETHChief Executive Officer
2,000
0.0122%
$13.79
$27,580
-31.93%
2026-08-20PurchaseBAGGER RICHARD Hdirector
1,000
0.0061%
$12.60
$12,600
-21.55%
2026-06-12PurchaseTaylor Carolyn E.director
1,415
0.0083%
$10.55
$14,928
+2.29%
2026-06-09PurchaseLEDERMAN SETHChief Executive Officer
5,000
0.0316%
$11.79
$58,950
+0.70%
2026-06-08PurchaseStillwell Richard Newcombdirector
5,000
0.0312%
$11.65
$58,250
-1.62%
2026-03-31PurchaseLEDERMAN SETHChief Executive Officer
5,000
0.0342%
$12.62
$63,100
-11.27%
2026-03-18PurchaseLEDERMAN SETHChief Executive Officer
15,000
0.1231%
$14.89
$223,350
-13.11%
2025-08-21PurchaseTaylor Carolyn E.director
418
0.0048%
$36.03
$15,061
-58.16%
2025-08-20PurchaseTreco Jamesdirector
250
0.0028%
$36.00
$9,000
-58.17%
2025-05-15PurchaseLEDERMAN SETHChief Executive Officer
4,000
0.0509%
$21.55
$86,200
-19.57%
2022-06-29PurchaseLEDERMAN SETHChief Executive Officer
20,000
0.0147%
$1.71
$34,200
-66.14%
2022-03-25PurchaseLEDERMAN SETHChief Executive Officer
100,000
0.0033%
$0.24
$24,500
-85.39%
2021-09-28PurchaseLEDERMAN SETHChief Executive Officer
12,000
<0.0001%
$0.61
$7,320
-66.66%
2021-05-25PurchaseGoodman Daniel Wintnerdirector
5,000
<0.0001%
$1.12
$5,600
-56.78%
2021-03-24PurchaseLEDERMAN SETHChief Executive Officer
16,733
<0.0001%
$1.32
$22,088
-51.21%
2020-12-30PurchaseLEDERMAN SETHChief Executive Officer
35,000
0.0001%
$0.68
$23,800
+41.83%
2020-08-31PurchaseTreco Jamesdirector
5,500
<0.0001%
$0.89
$4,895
+9.38%
2020-08-20PurchaseBell Margaret Smithdirector
5,391
<0.0001%
$0.93
$4,997
+4.67%
2020-08-17PurchaseSULLIVAN GREGORY MChief Medical Officer
20,000
<0.0001%
$1.03
$20,600
-5.45%
2020-08-14PurchaseTreco Jamesdirector
4,500
<0.0001%
$1.06
$4,770
-4.06%
Total: 116
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
LEDERMAN SETHChief Executive Officer
11005
0.0642%
$57,115.95450
<0.0001%
Stillwell Richard Newcombdirector
5000
0.0292%
$25,950.0010
Taylor Carolyn E.director
1833
0.0107%
$9,513.2720
<0.0001%
BAGGER RICHARD Hdirector
1000
0.0058%
$5,190.0020
Moss David JPRES, CEO, TRES, CFO, SECR
3250000
18.9493%
$16.87M10
DAUGHERTY BRUCESee remarks
100000
0.5831%
$519,000.0060
Saks Samuel Rdirector
51050
0.2977%
$264,949.5030
MARIO ERNESTdirector
50000
0.2915%
$259,500.00177
Rhodes John Bdirector
23470
0.1368%
$121,809.3050
SULLIVAN GREGORY MChief Medical Officer
21405
0.1248%
$111,091.9560
GERSHELL LELANDChief Financial Officer
19260
0.1123%
$99,959.4080
MATHER CHARLES E IVdirector
11830
0.069%
$61,397.7040
Bell Margaret Smithdirector
5391
0.0314%
$27,979.2910
OLUKOTUN ADEOYE Ydirector
5350
0.0312%
$27,766.5010
Goodman Daniel Wintnerdirector
5001
0.0292%
$25,955.1910
SAENGER BRADLEYChief Financial Officer
3079
0.018%
$15,980.0120
MORRIS JESSICA EDGARChief Operating Officer
1638
0.0096%
$8,501.2210
Treco Jamesdirector
250
0.0015%
$1,297.5030
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$9,405,928
107
12.61%
$74.85M
$1,701,941
56
17.58%
$93.09M
$66,137,559
49
6.29%
$89.66M
$77,146,704
43
13.28%
$93.12M
$26,786,140
22
-18.62%
$78.7M

TNXP Institutional Investors: Active Positions

Increased Positions52+133.33%2M+71.68%
Decreased Positions15-38.46%301,659-12.82%
New Positions17New997,980New
Sold Out Positions7Sold Out215,364Sold Out
Total Postitions76+94.87%4M+58.86%

TNXP Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$11,279.005.24%681,530+261,082+62.1%2025-09-30
Vanguard Group Inc$9,218.004.28%556,957+392,225+238.1%2025-09-30
Geode Capital Management, Llc$3,325.001.55%200,934+25,722+14.68%2025-09-30
Northern Trust Corp$2,808.001.31%169,687+5,665+3.45%2025-09-30
State Street Corp$2,525.001.17%152,544+29,287+23.76%2025-09-30
Capital Fund Management S.A.$1,042.000.48%62,948+62,948New2025-09-30
Millennium Management Llc$873.000.41%52,731+43,854+494.02%2025-09-30
Ubs Group Ag$854.000.4%51,581+29,118+129.63%2025-09-30
Fmr Llc$752.000.35%45,466+32,713+256.51%2025-09-30
Susquehanna Portfolio Strategies, Llc$686.000.32%41,45400%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.